For corporate buyers
See fit before you see the confidential part.
Provisionally gives buyer-side owners a non-confidential fit brief and commercial route map for protected independent inventions. Your team can reject, redirect, or invite a formal process without receiving enabling details first.
What you see first
A brief, bounded signal: category, problem, maturity, filing/publication/prototype status, ownership posture, likely business-unit fit, route hypothesis, and the disclosure boundary. It is designed to answer “who should own this?” and “is it worth inviting into our process?” — not “is this patent valid?” or “should we buy this?”
Useful routing answers are concrete: open innovation for relevance, a product lead for problem fit, R&D for technical adjacency, BD/corp dev for partnership logic, legal for submission terms, or a portal when that is the real gate. If the answer is no, you pass cleanly.
What stays with you
- Ownership of the intake path.You decide which function should see the first signal: open innovation, product, R&D, legal, BD, corp dev, or another owner.
- Protection for product teams.No confidential invention details go to technical reviewers unless your process allows it.
- Fast rejection and redirection.The brief is useful even when the right answer is “wrong team,” “wrong stage,” or “use this portal.”
- Your diligence process.NDA, counsel, review steps, patent diligence, commercial judgment, and deal terms remain yours.
Intake
Buyer-side owner intake
Tell us what your team can screen before formal disclosure.